| Gene symbol | EPHB4 | Synonyms | CMAVM2, HFASD, HTK, LMPHM7, MYK1, TYRO11 | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q22.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | EPH receptor B4 | ||||
| GTO ID | GTC1118 |
| Trial ID | JPRN-jRCT2033230299 |
| Disease | Ewing Sarcoma |
| Altered gene | EPHB4 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | EPHB4 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I study of non-viral gene-modified CAR-T cell therapy for ewing sarcoma or malignant solid tumors with expression of EPHB4 receptor |
| Year | 2023 |
| Country | Japan |
| Company sponsor | National Cancer Center Hospital East |
| Cohort 1 | |||||||||
|
|||||||||